Guillain-Barré syndrome: Difference between revisions

Jump to navigation Jump to search
Line 22: Line 22:


==[[Guillain-Barré syndrome pathophysiology|Pathophysiology]]==
==[[Guillain-Barré syndrome pathophysiology|Pathophysiology]]==
All forms of Guillain-Barré syndrome are due to an immune response to foreign antigens (such as infectious agents or vaccines) but mistargeted to host nerve tissues instead (a form of [[antigenic mimicry]]). The targets of such immune attack are thought to be [[gangliosides]], which are complex glycosphingolipids present in large quantities on human nerve tissues, especially in the [[nodes of Ranvier]]. An example is the GM1 ganglioside, which can be affected in as many as 20-50% of cases, especially in those preceded by ''[[Campylobacter jejuni]]'' infections. Another example is the GQ1b ganglioside, which is the target in the Miller Fisher syndrome variant (see below).
The end result of such [[autoimmune]] attack on the peripheral nerves is inflammation of [[myelin]] and conduction block, leading to a muscle [[paralysis]] that may be accompanied by sensory or [[autonomic]] disturbances.
However, in mild cases, axonal function remains intact and recovery can be rapid if remyelination occurs. In severe cases, such as in the AMAN or AMSAN variants (see below), axonal degeneration occurs, and recovery depends on axonal regeneration. Recovery becomes much slower, and there is a greater degree of residual damage. Recent studies on the disease have demonstrated that approximately 80% of the patients have [[myelin]] loss, whereas, in the remaining 20%, the pathologic hallmark of the disease is indeed [[axon]] loss.


==[[Guillain-Barré syndrome history and symptoms|History & Symptoms]]==
==[[Guillain-Barré syndrome history and symptoms|History & Symptoms]]==

Revision as of 16:20, 15 February 2012

Guillain-Barré syndrome
ICD-10 G61.0
ICD-9 357.0
DiseasesDB 5465
MeSH D020275

Guillain-Barré syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Guillain-Barré syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural history, Complications, and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Guillain-Barré syndrome On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Guillain-Barré syndrome

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Guillain-Barré syndrome

CDC on Guillain-Barré syndrome

Guillain-Barré syndrome in the news

Blogs on Guillain-Barré syndrome

Directions to Hospitals Treating Guillain-Barré syndrome

Risk calculators and risk factors for Guillain-Barré syndrome

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Priyamvada Singh, MBBS [2]

Overview

Pathophysiology

History & Symptoms

Physical Examination

Classification

Diagnosis

Other Diagnostic Studies

Differentiating Guillain-Barré syndrome from other Diseases

Treatment

Medical Therapy

Natural history, Complications, and Prognosis

Historical perspective

References

ca:Síndrome de Guillain-Barré de:Guillain-Barré-Syndrom it:Sindrome di Guillain-Barré he:תסמונת גיאן-בארה lb:Guillain-Barré-Syndrom ms:Sindrom Guillain-Barré nl:Syndroom van Guillain-Barré fi:Guillain-Barrén oireyhtymä sv:Guillain-Barrés syndrom

Template:WH Template:WS